Combined Targeting of mTOR and Akt Using Rapamycin and MK-2206 in The Treatment of Tuberous Sclerosis Complex

Tuberous sclerosis complex (TSC), caused by loss-of-function mutations in the TSC1 or TSC2 genes, is an autosomal dominant disease characterized by benign tumor formation in multiple organs. Hyperactivation of mammalian target of rapamycin (mTOR) is the primary alteration underlying TSC tumor. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Shuang, Lin, Wei, Wang, Li, Ni, Zhaofei, Jin, Fuquan, Zha, Xiaojun, Fei, Guanghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370499/
https://www.ncbi.nlm.nih.gov/pubmed/28367235
http://dx.doi.org/10.7150/jca.17205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370499/
https://www.ncbi.nlm.nih.gov/pubmed/28367235
http://dx.doi.org/10.7150/jca.17205

Ejemplares similares